Tevogen Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TVGN Nasdaq 2830 tevogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tevogen Inc.

UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC - Oct 8th, 2026 1:50 pm
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC - Oct 8th, 2026 12:10 pm
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements - Sep 30th, 2026 2:30 pm
Tevogen Bio Holdings Inc. Becomes Tevogen Inc. - Jul 29th, 2026 6:00 am
Tevogen Bio Announces 2026 Annual Meeting of Stockholders - Jul 13th, 2026 8:15 pm
Tevogen Announces Formation of a Healthcare Services Initiative - Jun 9th, 2026 1:30 pm
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue - May 28th, 2026 10:30 am
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization - May 21st, 2026 10:15 am
Letter to Shareholders from CEO Dr. Ryan Saadi - May 18th, 2026 10:15 am
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close - May 12th, 2026 9:45 am
Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization - May 4th, 2026 7:24 pm
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal - Apr 27th, 2026 9:50 am
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth - Mar 26th, 2026 10:45 am
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization - Mar 13th, 2026 12:45 pm
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical - Mar 5th, 2026 12:50 pm
Tevogen Announces Reverse Stock Split - Mar 4th, 2026 6:00 am